April 22, 2021 | Featured

Intract Pharma and NIBEC Enter into an Agreement to Develop a Novel Oral Peptide Therapy for Treatment of Ulcerative Colitis.

April 01, 2021 | Featured

Intract Pharma Enters into Research Collaboration with Ferring Pharmaceuticals to Evaluate Oral delivery of Monoclonal Antibodies for Treatment of Chronic Gastrointestinal Diseases

August 20, 2020 | Featured

Intract Pharma Limited and Celltrion Group announce collaboration for development of oral Infliximab.

May 26, 2020 | Featured

Intract Pharma and N&S Pharmacy Investment announce partnership to develop orally-delivered GLP-1R agonist peptide therapeutic

May 05, 2020 | Featured

Intract Pharma and Elasmogen Ltd announce collaboration to discover and develop novel, orally-delivered protein therapeutics

January 29, 2020 | Events

Intract Pharma to Present at the 22nd BIO CEO & Investor Conference

October 24, 2019 | Featured

Intract’s Soteria® and Phloral® Technologies Highlighted Among Revolutionary Approaches to Crack Oral Biologics Delivery Challenge

May 07, 2019 | Phloral

Carus Animal Health and Intract Pharma Enter Agreement to Develop Novel Drug Delivery Technology

April 05, 2019 | Featured

Intract Pharma Limited and Neopharma Japan Enter into a Collaboration to Develop a Novel Treatment for Gastrointestinal Diseases using Intract’s Proprietary Drug Delivery Technologies

Page: 1 2 3